Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options - DutchNews.nl Get link Facebook X Pinterest Email Other Apps April 27, 2020 Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options DutchNews.nl Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment